Background: Over the past 10 years, research into environmental risk factors for autism has grown dramatically, bringing evidence that an array of non-genetic factors acting during the prenatal period may influence neurodevelopment. Methods: This paper reviews the evidence on modifiable preconception and/or prenatal factors that have been associated, in some studies, with autism spectrum disorder (ASD), including nutrition, substance use and exposure to environmental agents. This review is restricted to human studies with at least 50 cases of ASD, having a valid comparison group, conducted within the past decade and focusing on maternal lifestyle or environmental chemicals. Results: Higher maternal intake of certain nutrients and supplements has been associated with reduction in ASD risk, with the strongest evidence for periconceptional folic acid supplements. Although many investigations have suggested no impact of maternal smoking and alcohol use on ASD, more rigorous exposure assessment is needed. A number of studies have demonstrated significant increases in ASD risk with estimated exposure to air pollution during the prenatal period, particularly for heavy metals and particulate matter. Little research has assessed other persistent and non-persistent organic pollutants in association with ASD specifically. Conclusions: More work is needed to examine fats, vitamins and other maternal nutrients, as well as endocrine-disrupting chemicals and pesticides, in association with ASD, given sound biological plausibility and evidence regarding other neurodevelopmental deficits. The field can be advanced by large-scale epidemiological studies, attention to critical aetiological windows and how these vary by exposure, and use of biomarkers and other means to understand underlying mechanisms.
Introduction
Both genetic and environmental lines of research have led to recognition of the aetiological complexity of autism spectrum disorder (ASD). Although the contribution from the environment was originally thought to be low, based in part on remarkably high monozygotic twin concordance in earlier small studies 1, 2 and a limited understanding of gene-by-environment interactions, evidence currently supports a greater environmental contribution. In the largest twin study to date, Hallmayer and colleagues found that environment accounted for 55% of the variance in autism risk among twins. 3 Current thinking suggests that, for most individuals, multiple causes likely operate, and these may include a number of genes and environmental factors. Over the past decade, there has been exponential growth in the number of environmental factors studied in association with ASD. Although the field is still in its early stages, studies grounded in biologically plausible pathways and focused on critical time periods of neurodevelopment have suggested promising risk and protective factors, as well as avenues for future research. This article discusses certain environmental factors that may alter risk for ASD when exposure occurs during the preconception and prenatal periods.
The environment can be defined broadly as all nongenetic factors, from viruses to medications, from chemicals or physical agents to social and cultural influences. Due to this broad scope and the substantial body of emerging research on these environmental topics, we have focused our review specifically on modifiable maternal lifestyle factors and environmental chemicals. Potentially modifiable factors are highlighted, as these offer an opportunity for altering behaviours at the individual level or taking action at the societal level in order to change exposure and thereby improve public health through reduced incidence of ASD. Table 1 outlines criteria for inclusion in this review.
Environmental factors

Potential mechanisms
Environmental exposures may influence brain development at different stages, including formation and closure of the neural tube, cell differentiation and migration, formation of structures such as cortical mini-columns, synaptogenesis and myelination. Immune dysregulation or oxidative stress from xenobiotic chemicals or their metabolites, and deficiencies in nutrients or essential fatty acids may also play a pathogenic role. Further, environmental factors are likely to act in concert with susceptibility genes. Such interactions may involve epigenetics, leading to changes in gene expression and/or to a transgenerational mechanism. Additionally, genes may affect the metabolism, receptors and activity of xenobiotic chemicals, thereby altering the biochemistry of the brain. Evidence that de novo changes to DNA, i.e. alterations not inherited from parents, are associated with ASD risk suggests that environmental exposures may induce damage to the genetic code.
activate can lead to various phenotypic manifestations, including autism but also attention deficits or cognitive impairments. In light of such lack of specificity, comparisons between persons with ASD and those with other developmental or mental health conditions may fail to identify causative factors. Serious biases, usually towards the null, could also arise from use of unaffected siblings or friends in case-control studies, a common strategy in psychiatric epidemiology. Ecological studies, where summary information rather than individual data is used for both exposures and outcomes (e.g. average emissions of a pollutant in relation to rates of ASD) are especially vulnerable to confounding and other biases; fortunately, cohort and case-control designs with individual-level data are becoming the norm in ASD research. Moreover, with well-defined source populations and existing exposure databases or specimen archives, some case-control studies can achieve as high quality as cohort studies.
Timing is critical for neurodevelopment, and hence for studying environmental impacts. Though findings from neuroanatomical, epidemiological and animal studies support prenatal origins of ASD, [4] [5] [6] [7] [8] [9] the implicated vulnerable window varies by mechanism or by risk factor (Figure 1 ). Thus, multiple critical periods of increased susceptibility for ASD likely exist and may extend from pre-conception through the first few years of life.
Proxies for environmental exposures
Some environmental factors may serve as markers rather than causes of higher risk. Although some proxies for environmental factors are not directly modifiable, studying them can provide aetiological clues. Season serves as a proxy variable for diverse exposures, such as influenza, other infections, sunlight/vitamin D, other nutritional factors or pesticides. Seasonality of birth or conception has been associated with increased risk of autism in several studies. [10] [11] [12] Short interpregnancy interval (IPI) is another proxy strongly associated with ASD in two very large cohort studies. 13, 14 Among other explanations (cultural, family planning or lifestyle factors), short IPI may indicate maternal depletion of essential nutrients including folate, as these become depleted during pregnancy and can remain low for up to a year postpartum. [15] [16] [17] 
Maternal Lifestyle Factors
Background Several lifestyle factors have been examined in relation to ASD (Table 2 ). Because cigarette smoking data are often available in medical and registry databases, maternal smoking was one of the first factors to be examined for associations with ASD. More recently the gap in research on lifestyle factors, such as other substance use and maternal nutrition, has begun to be addressed.
Maternal nutrition
Despite a growing number of studies investigating diet and nutrition among children affected with ASD, very little research has directly explored maternal nutrition in 145 and experimental models of features of autism. 9 6. Human study We focus on human studies in which clinical or reported ASD is the outcome, although reference is made to experimental animal models where relevant for discussions of plausibility and/or mechanisms association with risk of ASD in the offspring. However, maternal nutrition is essential to fetal brain development, and maternal nutrient deprivation has been associated with strong increases in risk of schizophrenia, 18 neural tube defects 19, 20 and other adverse neurodevelopmental outcomes. [21] [22] [23] Nutritional deficiencies are particularly common during pregnancy due to increased metabolic demands imposed by a growing placenta, fetus and maternal tissues, 24, 25 and have been shown to influence brain development in terms of structure and function. There is strong biological plausibility, therefore, that maternal nutrition might influence ASD risk as well.
Prenatal vitamins and folic acid
In a large population-based case-control study, consumption of prenatal vitamin supplements near the time of conception was associated with about 40% reduction in risk for ASD. 26 This significant finding was adjusted for maternal education and child's birth year. The study also reported significant gene-environment interactions, suggesting even stronger protection from prenatal vitamins that contain high levels of folic acid when the children or their mothers carried gene variants leading to less efficient folate-dependent one-carbon metabolism. In further work, Schmidt and colleagues (2012) reported significantly lower mean total folic acid intake (quantified from vitamins, other supplements and breakfast cereals) in the first month of pregnancy for mothers of children with ASD (n ¼ 429) than for mothers of typically developing children (n ¼ 278). The study also found a significant trend of decreasing ASD risk as mean daily folic acid intake increased (P trend ¼ 0.001) 27 Reported intake of 600 ug of folic acid (the recommended dietary allowance for pregnant women in the USA 28 ) was associated with protection only when either the mother or the child carried a common variant in the methylenetetrahydrofolate reductase gene, MTHFR 677 C>T, which leads to less efficient folate metabolism. A Norwegian cohort study of 85 176 children, of whom 270 were diagnosed with ASD, 29 tightly replicated these folic acid supplement findings in a country where cereal grains are not fortified with folic acid (as they are in the USA). Risk for autistic disorder was 40% lower among those whose mothers prospectively reported at 18 weeks of gestation having taken folic acid supplements periconceptionally (6 weeks before and after conception). These studies are among the first to suggest modifiable factors that could reduce risk of autism. Periconceptional Gestational Weeks   1  2  3  4  5  6  7  8  9  1 6  2 0  2 2  2 8  3 8 Brain collected information on use since becoming pregnant at the first antenatal visit which usually takes place before the end of the first trimester (median 10 weeks of gestation). folic acid improves other neurodevelopmental and behavioural outcomes, including reduced risk for neural tube defects, hyperactivity and severe language delay, as well as improved attention, social competence, and verbal and executive function. [30] [31] [32] [33] [34] Around the time of implantation, when the epidemiological data suggest folic acid to be most important, mammalian embryos undergo extensive DNA demethylation, followed by reestablishment of methylation patterns. 35 Because folate provides a major source of onecarbon (methyl) groups, mechanisms involving methylation-and hence expression or activity of genes, proteins and neurotransmitters-may link folic acid to ASD. 27 Impaired methylation capacity 36 and altered DNA methylation have been implicated in ASD aetiology.
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Fish and fish oil supplements Maternal fish intake may also be relevant to neurodevelopment and ASD, both as a source of fatty acids and vitamin D (which may confer protective effects) and as a potential source of mercury (which is deleterious to fetal brain development). As reviewed by Oken and Bellinger, 38 the majority of studies examining maternal fish intake and child neurodevelopmental outcomes have suggested that higher maternal fish consumption is associated with higher child development scores, though type of fish and mercury levels need to be taken into account. The only study to date to examine maternal fish intake in association with ASD specifically did not find any relationship. 39 The study was limited, however, by low variation in fish intake and few women with fish intake reported during pregnancy. The Norwegian cohort study on folic acid supplements also found no association between autism and prenatal fish oil supplements. 29 
Fatty acids
Developing fetuses require maternal stores of omega-3 fatty acids for optimal brain development. 40, 41 The only study to date that has examined maternal fat and fatty acid intake during pregnancy in association with ASD 39 used prospectively collected dietary data from validated food frequency questionnaires in a subgroup of a large US cohort, the Nurses' Health Study II. Children of mothers with higher intake of polyunsaturated fatty acids (PUFA) before and during pregnancy had reduced risk of ASD relative to children of mothers with the lowest PUFA intake. In addition, women with very low intakes (the lowest 5% of the distribution) of omega-3 fatty acids had a significantly increased risk of having offspring with ASD relative to those in the middle 90% of the distribution.
Vitamin D Low maternal (and thus fetal) vitamin D levels have been hypothesized as risk factors for ASD, 42 based on reports of increased rates of ASD among children of dark-skinned immigrant mothers who moved to high latitudes 43 and among children born or conceived in certain seasons. 12, 44 No significant differences were observed in serum 25-hydroxyvitamin D, comparing mothers of children with ASD to mothers of children without ASD among Somalis or Swedes. 45 However, the study had a small sample size and lacked vitamin D measurements during gestation. Another study found maternal serum 25-hydroxyvitamin D concentrations from around the 18th week pregnancy did not predict the child's total Autism-Spectrum Quotient (AQ) scores in early adulthood. 46 However, the study was too small to examine ASD diagnoses. No study to date has examined the relationship between maternal or gestational vitamin D and ASD diagnosis. Despite a lack of epidemiological evidence for a maternal vitamin D effect on ASD risk, vitamin D influences neuronal differentiation, metabolism of neurotrophic factors and neurotoxins, protection from brain inflammation, endocrine functions and fetal brain growth, providing ample biological plausibility for a relationship. Rats born to vitamin D-deficient dams have profound alterations in the brain, 47 and human maternal vitamin D insufficiency has been linked with impaired language development of the child at ages 5 and 10 years. 46 
Substance use
Cigarette smoking A number of investigations have assessed maternal smoking in association with ASD, each with limitations, and overall producing inconsistent findings. 6, 7, [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] Earlier work lacked adjustment for socioeconomic factors that likely confounded associations 6, 7, 48, 49 or adjusted for potentially mediating variables (i.e. birthweight 52, 53 ) which could have masked an elevated risk. A large registry-based study of 3958 ASD cases and 38 983 controls in Sweden found no association after adjustment for family sociodemographic factors. 54 The two most recent studies, a population-based study of 633 989 US children 57 and a Finnish nested case-control study, 58 found no association between maternal smoking and ASD, but did find an association with high-functioning autism or pervasive development disorder. Nevertheless, collecting accurate data on smoking can be challenging, and under-reporting in medical records, by self-report, or from birth certificates 57 in these studies could have led to exposure misclassification and bias towards the null. Maternal smoking could influence neurodevelopment and risk for ASD through mechanisms such as placental insufficiency, reduced blood flow and oxygen deprivation in the brain, 59 changes in fetal brain gene expression, 60 altered nicotinic receptors, 61 persistent changes in neurotransmitter activity and turnover 62, 63 and increased intrauterine testosterone. 64 Prenatal smoking in some mothers may also be an indicator of underlying psychological problems that themselves could influence risk in the offspring. 65 Despite numerous studies, evidence for maternal cigarette smoking as a risk factor for ASD remains contradictory. Though the latest studies do not support a strong effect of maternal smoking on autism risk, it is premature to draw conclusions, given: (i) limitations of exposure assessment in studies; (ii) evidence for a harmful effect for higher-functioning autism in well-conducted investigations; (iii) strong biological plausibility; and (iv) evidence for effects on social problems and other psychiatric disorders. 66 Because smoking has shown a propensity for gene by environment interaction effects in relation to other birth outcomes, 67,68 investigation of maternal smoking in combination with genetic susceptibility, and potential epigenetic effects of cigarette smoke components, may yield more definitive answers.
Alcohol
Maternal alcohol consumption can be teratogenic; high prenatal alcohol exposure impairs neurodevelopment in humans, [69] [70] [71] and in animal studies produces social avoidance 72 and structural brain anomalies congruent with those observed in children with ASD. 73 However, surprisingly few rigorous studies have examined maternal alcohol use and ASD risk. A pedigree analysis of families that have a child with ASD suggested an association with reported alcoholism in females among first-and second-degree relatives, 74 whereas a nested case-control study in Sweden found no association between ASD and alcohol and drug addiction/ misuse. 75 Other results on the relationship of maternal alcoholism to ASD are also conflicting. [74] [75] [76] [77] [78] [79] In the largest study of prenatal alcohol exposure and ASD risk, Eliasen and colleagues examined a populationbased cohort of 80 552 Danish children and their mothers. 69 Average self-reported alcohol consumption was not associated with either ASD or infantile autism. A probably spurious association was found between a single binge episode and lower ASD risk. Selection bias arising from low participation in the study (30%) and reporting bias may have distorted the association, but the prospective design and large size suggest that this is the best evidence to date on maternal alcohol intake and ASD.
Other substances Maternal misuse of other drugs for recreational purposes, such as marijuana and cocaine, has not been investigated in studies meeting criteria for this review (case reports only). Similar to alcohol and smoking, there is biological plausibility for such exposures to interfere with brain development [80] [81] [82] and increased susceptibility to ASD, but assessment tends to be difficult and prone to inaccuracies and bias. As noted previously, maternal use of pharmaceutical medications, which have been studied more extensively, [83] [84] [85] [86] is outside the scope of this review, as are herbal preparations.
Environmental Chemicals
Background Despite historical evidence of reproductive and neurodevelopmental aberrations with exposure to chemicals like lead or pesticides, federal requirements that substances be tested for long-term behavioural consequences have been slow to evolve. Tens of thousands of compounds present in consumer products and other settings remain unregulated at the US federal or state level, 87 with many of these likely to have stronger impact on fetuses and children, as compared with adults. The list of suspected aetiological agents for ASD begins with known neurotoxins and neurodevelopmental toxins, but also extends to compounds that operate via mechanisms initiated outside the central nervous system (CNS), such as immune dysregulation, altered lipid metabolism and mitochondrial dysfunction, among others. Both persistent and non-persistent organic chemicals may influence ASD. Finally, chemicals having widespread contact with human populations deserve close scrutiny as highly prevalent exposures, even when their effects are modest on an individual basis, can greatly impact public health. Environmental chemicals that have been examined in studies meeting our inclusion criteria are summarized in Table 3 .
Air pollution
A growing body of research has emerged on air pollution, or proxies for it, in relation to ASD. [88] [89] [90] [91] [92] [93] [94] however, was that exposures were based on modelled estimates derived for residences 2 years after the birth, and thus may not have adequately captured prenatal exposure. The first investigation not restricted to one region of the country was an analysis of Nurses' Health Study II, including 325 maternally-reported cases and 22 000 controls from across the USA. These authors also found significantly elevated risk of ASD from air pollutants, 91 using US EPA-modelled levels of HAPs for the year of birth. ORs were remarkably similar to the Windham et al. study, ranging from 1.5 (overall metals) to 2.0 (diesel and mercury), and with statistically significant positive linear trends. In addition, associations were stronger for male children for most pollutants. A study of children from North Carolina and West Virginia also found elevated risk of ASD for numerous air pollutants, but not after adjusting for demographic factors. 89 However, variability in pollutant concentrations was low, and the referent group consisted of children with speech and language impairments, a group which could be linked to the same exposures. Volk and colleagues conducted two studies on the topic, using data from a large population-based case control study in California, the CHildhood Autism Risks from Genetics and the Environment (CHARGE) study. 96 The first of these (n ¼ 304 cases and 259 controls) examined proximity to a major freeway as a proxy for air pollution.
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Residence within 309 meters (m) of a freeway at time of delivery (as compared with >1419 m) was linked, in analyses adjusted for sociodemographics, with nearly a doubling in odds of having a child with ASD. This association strengthened somewhat when examining third-trimester exposure. Intermediate distances were not associated with ASD, nor was proximity to smaller roadways, which is consistent with the established high concentration of pollutants near major freeways and a decline in particulate matter to background levels beyond 300 m from a major freeway. 97 In further analyses, these authors examined specific traffic-related air pollutants using EPA models (similar to previous studies), but with improved specificity on timing of exposure. 93 Risk was highest with gestational and first year of life exposures for overall traffic-related air pollution, nitrogen dioxide and particulate matter less than 2.5 and less than10 lm in diameter (PM 2.5 and PM 10).
The largest study to date of air pollution and ASD (n ¼ 7603 cases and 10 matched controls per case) was conducted in Los Angeles County and used geocoded residences at the time of delivery linked to air pollutant monitoring data supplemented with land-use regression data for nitrogen dioxide (NO 2 ) and nitrogen monoxide (NO). 88 Risk for ASD was elevated for higher estimated ozone and NO 2 exposure during the entire pregnancy, in models adjusted for a range of sociodemographic confounders. Analyses from one report suggesting a strong association of ASD with organochlorines and a moderate one with a pyrethroid require confirmation in independent samples, preferably with gold standard diagnoses EPA, Environmental Protection Agency; PAH, polycyclic aromatic hydrocarbon.
a As for Table 2 , references meeting study inclusion criteria (Table 1) .
Associations increased when two-pollutant models were used, and for those in the lowest educational stratum. Thus, a rapidly growing literature suggests potential associations between air pollutants and ASD risk. Because air pollution is a highly complex and variable mixture of different compounds that are highly correlated, determining the impact of specific chemicals is difficult. Additionally, although most analyses adjusted for sociodemographic factors such as parental education, socioeconomic status (SES) or income, race/ethnicity and/or parental age, residual confounding could still be present, particularly by SES factors that influence the likelihood of a diagnosis. Confounding by other factors that may affect child outcomes, e.g. noise pollution through sleep disturbances, should also be considered. Bias could also be introduced by misclassification or missingness of exposure assessments. Nevertheless, a number of potential biological pathways might explain observed associations, including direct effects on CNS development, oxidative stress, dysregulation of repair mechanisms or compromise of the blood-brain barrier. Animal studies showing alterations in blood-brain barrier signalling following exposure to diesel particulates, 98 and alterations in neural circuitry and behavioural deficits following prenatal exposure to HAPs, 99,100 lend support to these hypothesized pathways.
Persistent organic pollutants
Since the 1960s, a number of organic compounds have been identified that are persistent, widely distributed throughout the environment and toxic to both wildlife and human health. These compounds, POPs (Persistent Organic Pollutants), targeted for reduction and/or elimination (http://chm.pops.int/Convention/ConventionText/ta bid/2232/Default.aspx), include certain pesticides, industrial chemicals and by-products of industrial processes. Some POPs have demonstrated adverse effects on neurodevelopment. Several POPs are endocrine-disrupting chemicals (EDCs). One such class of chemicals is polychlorinated biphenyls (PCBs). These have only been studied in association with ASD in one investigation to date. 101 This small pilot investigation found a non-significant elevation of odds for ASD in association with measured concentrations of PCBs from maternal samples taken at delivery (Table 3) . Despite little research, mechanistic considerations suggest the potential importance of EDCs. The fetus depends on maternal thyroid hormones (T3 and T4) during early gestation, as they regulate neuronal growth, cell migration and differentiation in the hippocampus, cerebral cortex and cerebellum. 102 The only human study on ASD and thyroid hormones found an association with very low levels at birth. 103 In mouse models, changes in thyroid hormone levels affected dendritic development of Purkinje cells, 104 notable given Purkinje cell loss is one of the most highly replicated findings in ASD. 105 For these reasons, disruption of thyroid hormones during pregnancy has been hypothesized as a potential aetiological pathway for autism. 106 The strong male:female ratio in autism of over four has been hypothesized to indicate that steroid hormones or their targets 107 or early sexual differentiation of the brain might play a role in aetiology, and both testosterone and estradiol influence fetal brain development. EDCs may also act in combination with genes to influence ASD risk. Some, but not all, of the pesticides discussed below are classified as POPs.
Pesticides
Pesticides are typically designed to damage the nervous systems of the targeted species, and often act on neurotransmission. Several pesticides have been classified as POPs (http://chm.pops.int/Convention/ThePOPs/tabid/673/Defa ult.aspx) and/or have endocrine-disrupting properties. 108 Western countries without endemic malaria have reduced use of most organochlorine pesticides, due to their persistence and adverse effects on wildlife, but some continue to be used for other purposes, such as head lice. In one study, ASD risk was elevated in children from households located near agricultural applications of organochlorines during the first trimester. 109 Organophosphate insecticides, which degrade rapidly, replaced organochlorines for many uses, and have been widely applied both agriculturally and residentially, though production of residential products was banned by the US EPA in 2001. In a cohort study conducted in a farm worker community, poorer scores on a subscale of the Child Behavior Checklist measuring symptoms for pervasive developmental disorder (PDD) were associated with higher levels of organophosphate pesticide metabolites in urine samples from pregnancy. 110 Similarly, higher umbilical cord blood plasma concentrations of a common orgaphophosphate, chlorpyrifos, were also associated with PDD symptoms in early childhood in a New York City cohort. 111 Other investigations found organophosphates related to deficits in motor coordination, visuospatial performance and memory, 112 and decrements in cognitive development, 113 with evidence that a gene involved in metabolizing these chemicals, paraoxonase 1 (PON1), may be a susceptibility factor. Moreover, a neuroimaging study by Rauh and colleagues demonstrated that children with higher chlorpyrifos concentrations had altered volume in cortical regions of the brain that have been associated with attention, receptive language processing, social cognition and inhibitory control. 114 Since the ban on organophosphates for household products, other pesticides have become increasingly common 115 but have not been reported in relation to ASD. As of 2009, over 3500 products registered in the USA contained synthetic pyrethroids or their naturally derived counterparts, pyrethrins. 116 Despite relatively short half-lives in humans, pyrethroid metabolites were found in over 70% of adults in the USA, 117 reflecting common usage and ubiquitous presence in household products. Other pesticides of concern include imidacloprid and fipronil, both used in insecticide gels, flea sprays and other products to eliminate pests. These products might influence neurodevelopment through a variety of mechanisms (reviewed by Shelton and colleagues 118 ): interference with establishment of serotonergic systems; altered monoamine oxidase or acetylcholinesterase activity or GABA function; reduced expression of GABA receptors; mitochondrial dysfunction; and endocrine disruption. 106 Pesticides may also affect calcium signalling.
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Non-persistent organic pollutants
Not all compounds deleterious to neurodevelopment are persistent; some are short-lived. Phthalates, a class of EDC that may influence ASD, are used in cosmetics, lotions, fragrances and building materials, and have anti-androgenic properties. 121 In children, prospective research found associations of some phthalate metabolites with body size, 122 conduct disorder or attention problems , 123 and social deficits. 124 In particular, phthalate metabolites measured in third-trimester maternal urine were associated with poorer scores on several subscales of the Social Responsiveness Scale. 124 Also, a recent Swedish study investigating indoor environmental factors found an unexpected doubling of risk for ASD in children whose homes had vinyl (PVC) flooring in the child and parent bedrooms; 51 PVC flooring is a significant source of airborne phthalates. Both BPA 125 and phthalates 126 have also been linked to thyroid dysfunction, discussed above. Continued investigation of these short-lived endocrine-disrupting chemicals in association with neurodevelopment and autism is needed.
Suggested chemicals for future research
Above, we have highlighted environmental chemicals and dietary factors for which little research has yet been conducted, despite animal or in vitro evidence supporting biological plausibility. Here we mention a few others that deserve attention. Although PCBs have shown associations with cognitive impairment or behavioural problems, 127, 128 other candidate EDCs include dioxins, polybrominated diphenyl ethers (PBDEs), 129 bisphenol A (BPA) and perfluorinated compounds. These have demonstrated a wide range of toxic effects. For instance, PBDEs (used as flame-retardants in textiles, including children's clothing, and plastic cases for electronics) easily cross the placenta 130 and produce hyperactivity and altered motor behaviour and development in rodents 131, 132 and in humans, deficits in mental and psychomotor development 133 and increased attention problems at school age. Highest levels are found in the youngest individuals. 134 Perinatal treatment of Mecp2 mice with one of the most abundant PBDEs, BDE-47, resulted in hypomethylation of adult brain DNA, with accompanying reduced sociability that was independent of genotype. 135 This demonstration of perinatal PBDE effects on social behaviours in genetically predisposed mice suggests potential relevance to ASD in humans carrying certain genetic susceptibilities. To date, little research has addressed the influence of specific environmental factors on epigenetics, on gene expression relevant to neurodevelopment, or in genetically susceptible subsets of the population. As another example, BPA, a plasticizer found in products including plastic food wrappings, can linings, plastic drink and baby bottles, is a non-persistent organic pollutant with estrogenic properties, and has been linked to obesity 136 and diabetes 137 which, in pregnant women, have been associated with increased risk for ASD in offspring. 138 A prospective study found maternal BPA metabolites were associated with an increase in externalizing problem behaviours, 139 suggesting relevance to ASD and need for investigation.
Summary and Future Directions
Recently, considerable progress has been made in uncovering clues about environmental contributions to autism. Rapidly emerging evidence supports potential roles for preconception or prenatal maternal nutrition, lifestyle and exposures to environmental chemicals found in air pollution or pesticides. Other environmental factors acting during this period but not covered in this article, including infections, medications and pregnancy complications, also have considerable support for an association with ASD. It is clear that there is no single or universal cause of autism; rather, many environmental and genetic factors are likely involved, and the specific subsets of factors that are operating will vary across different individuals. Evidence regarding a protective association of maternal nutrition with ASD, particularly folic acid, is strong, and appears unlikely to be explained by confounding. The literature on air pollution shows remarkable consistency, though measurement accuracy and possible residual confounding need to be addressed; also, the lack of solid links with cigarette smoking raises questions about the coherence of this work, given similar constituents in the two. At present, a few studies support a potential role for organophosphate pesticides in relation to ASD, as well as phthalate exposures. For most other modifiable environmental factors in the periconception and prenatal periods, the literature is inconsistent and/ or of insufficient quality and quantity.
As noted, many of the factors reviewed here have associations with a broader class of neurodevelopmental or psychiatric conditions, and therefore may not be unique risk factors for autism. Genetic factors or critical time periods may influence how these xenobiotics or non-inherited conditions alter brain connectivity and determine whether the exposure results in autism as opposed to other deficits. Large gene-by-environment studies are one approach to capture the complexity of this disorder. Other research gaps include determination of critical aetiological windows for environmental exposures and how these vary by type of exposure (see Figure 1) , along with continued investigation into maternal nutritional, obstetric, metabolic and other factors during the pre-conception, prenatal and perinatal periods, and disentangling the role of maternal and paternal influences. Although the preconception and prenatal periods likely have the strongest impact, continued plasticity of the central nervous system implies that further insults or protective factors in the first year or two of life may also contribute to the phenotypic development of the child and concomitant risk for ASD.
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